AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

INSMED Inc Director's Dealing 2013

Jan 11, 2013

30150_dirs_2013-01-11_8ba87635-306f-4b86-b589-f1619efba01c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INSMED INC (INSM)
CIK: 0001104506
Period of Report: 2013-01-09

Reporting Person: Lewis William (President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-01-09	Common Stock	P	10770	$6.90	Acquired	24338	Direct

Footnotes

F1: Open market purchase pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F2: Average purchase price of shares acquired.